Hong Leong Investment Bank analyst Chee Kok Siang has initiated coverage on Optimax Holdings with a Buy rating and a target price of RM0.96, implying a 43.3% upside. Chee likes the company for its strong positioning to capitalise on Malaysia’s fast-growing medical eye care industry, and its exposure to upcoming thematic plays in 2026 (Malaysia Year of Medical Tourism) and 2027 (Johor’s next consumption wave).